Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients

ConclusionsThese results suggest that denosumab may be a strong OP treatment option for BP-unresponsive patients.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research